Your browser doesn't support javascript.
loading
Epidemiology of measles in vaccinated people, Spain 2003-2014. / Epidemiología del sarampión en personas vacunadas, España 2003-2014.
Risco-Risco, Carlos; Masa-Calles, Josefa; López-Perea, Noemí; Echevarría, Juan Emilio; Rodríguez-Caravaca, Gil.
Afiliación
  • Risco-Risco C; Unidad de Medicina Preventiva y Salud Pública, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España. Electronic address: carlosriscorisco@yahoo.es.
  • Masa-Calles J; Centro Nacional de Epidemiología, CIBERESP, Instituto de Salud Carlos III, Madrid, España.
  • López-Perea N; Centro Nacional de Epidemiología, CIBERESP, Instituto de Salud Carlos III, Madrid, España.
  • Echevarría JE; Laboratorio de Referencia e Investigación en Enfermedades Víricas Inmunoprevenibles, Unidad de Aislamiento y Detección de Virus, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, España.
  • Rodríguez-Caravaca G; Unidad de Medicina Preventiva y Salud Pública, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España.
Enferm Infecc Microbiol Clin ; 35(9): 569-573, 2017 Nov.
Article en En, Es | MEDLINE | ID: mdl-27262819
INTRODUCTION: During the final phase of measles elimination rigorous investigation of each individual case becomes fundamental to confirm or discard cases, particularly among vaccinated people, since they experience a milder disease, and laboratory diagnosis is more complex. Our study focused in the epidemiology of measles in vaccinated people. METHODS: Longitudinal study on measles cases in two dose vaccinated people in Spain from 2003 to 2014. RESULTS: We confirmed 138 measles cases (90 of them, laboratory confirmed) in people with two doses of vaccine. The median of time from last vaccination to rash onset showed a lineal trend (P<.001), in parallel with the number of doses of vaccine received (0, 1, 2 doses). Among confirmed cases, the hospitalization risk decreased inversely proportional to the number of administered vaccine doses (linear trend, P<.001). Only in 23.9% of confirmed cases and 50% of discarded cases the guidelines about sample taking were fulfilled. 50% of samples in two dose vaccinated people were taken without fulfilling time delay criteria. 16.7% (36/215) of discarded cases with a negative IgM result did correspond to samples taken early (first 72h after rash) and could represent false negatives. CONCLUSION: Our results highlight the importance of fulfilling properly the guidelines for laboratory diagnosis in order to confirm or discard every measles case, especially in two dose vaccinated people. When a negative IgM result is obtained in early samples a new IgM test should be practiced, as well as a PCR test, in order to avoid infra-detection of cases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Sarampión Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans País/Región como asunto: Europa Idioma: En / Es Revista: Enferm Infecc Microbiol Clin Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Sarampión Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans País/Región como asunto: Europa Idioma: En / Es Revista: Enferm Infecc Microbiol Clin Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2017 Tipo del documento: Article